How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? / Aboy, Mateo; Cohen, Glenn ; Liddell, Kathleen; Liddicoat, Johnathan; Crespo, Cristina; Gerke, Sara; Minssen, Timo.

I: Nature Biotechnology, Bind 37, Nr. 10, 02.10.2019, s. 1118–1125.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Aboy, M, Cohen, G, Liddell, K, Liddicoat, J, Crespo, C, Gerke, S & Minssen, T 2019, 'How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?', Nature Biotechnology, bind 37, nr. 10, s. 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

APA

Aboy, M., Cohen, G., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S., & Minssen, T. (2019). How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology, 37(10), 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

Vancouver

Aboy M, Cohen G, Liddell K, Liddicoat J, Crespo C, Gerke S o.a. How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology. 2019 okt. 2;37(10):1118–1125. https://doi.org/10.1038/s41587-019-0265-1

Author

Aboy, Mateo ; Cohen, Glenn ; Liddell, Kathleen ; Liddicoat, Johnathan ; Crespo, Cristina ; Gerke, Sara ; Minssen, Timo. / How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?. I: Nature Biotechnology. 2019 ; Bind 37, Nr. 10. s. 1118–1125.

Bibtex

@article{e380d499b22e4851a81b9573f6fdda05,
title = "How does emerging patent case law in the US and Europe affect precision medicine?: How will today{\textquoteright}s patent law affect tomorrow{\textquoteright}s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?",
abstract = "Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today{\textquoteright}s law will affect tomorrow{\textquoteright}s innovation.",
keywords = "Faculty of Law, pecision medicine, patents, Biomarkers, diagnostics, Artificial intelligence, big data, algorithm engineering",
author = "Mateo Aboy and Glenn Cohen and Kathleen Liddell and Johnathan Liddicoat and Cristina Crespo and Sara Gerke and Timo Minssen",
year = "2019",
month = oct,
day = "2",
doi = "10.1038/s41587-019-0265-1",
language = "English",
volume = "37",
pages = "1118–1125",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "nature publishing group",
number = "10",

}

RIS

TY - JOUR

T1 - How does emerging patent case law in the US and Europe affect precision medicine?

T2 - How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

AU - Aboy, Mateo

AU - Cohen, Glenn

AU - Liddell, Kathleen

AU - Liddicoat, Johnathan

AU - Crespo, Cristina

AU - Gerke, Sara

AU - Minssen, Timo

PY - 2019/10/2

Y1 - 2019/10/2

N2 - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

AB - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

KW - Faculty of Law

KW - pecision medicine

KW - patents

KW - Biomarkers

KW - diagnostics

KW - Artificial intelligence

KW - big data

KW - algorithm engineering

UR - https://rdcu.be/bSLBa

UR - https://www.nature.com/articles/s41587-019-0265-1

U2 - 10.1038/s41587-019-0265-1

DO - 10.1038/s41587-019-0265-1

M3 - Journal article

C2 - 31578504

VL - 37

SP - 1118

EP - 1125

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 10

ER -

ID: 213793813